CN110664692A

CN110664692A - Eye cream for smoothing fine wrinkles and tightening skin

Info

Publication number: CN110664692A
Application number: CN201911062541.6A
Authority: CN
Inventors: 柯映华; 张目; 李继德; 胡家逢
Original assignee: SHANGHAI YUEMU COSMETICS Co Ltd
Current assignee: SHANGHAI YUEMU COSMETICS Co Ltd
Priority date: 2019-11-03
Filing date: 2019-11-03
Publication date: 2020-01-10

Abstract

The invention discloses an eye cream for smoothing fine wrinkles and tightening skin, which mainly comprises the following components in percentage by weight: 1-5% of an extract of spilanthol camomile (ACMELLA OLEERACEA), 0.5-5% of an extract of Gigartina astera (GIGARTINA STELLATA), and 0.1-0.5% of a 1 ‰ aqueous solution of palmitoyl tripeptide-1.

Description

Eye cream for smoothing fine wrinkles and tightening skin

Technical Field

The invention relates to the field of cosmetics, in particular to eye cream for smoothing fine wrinkles and tightening skin.

Background

Skin aging is a progressive physiological process and is also influenced by factors such as environment, lifestyle, diseases, and the like. People living in cities have fast and irregular life rhythm, often stay up all night and excessively use electronic products, so that eye skin is more easily injured. With age, the skin is no longer fine and rough to the touch. The dry lines and roughness give the skin a haggarbled appearance. Ultraviolet rays, environmental pollution, etc. may cause damage to the skin, causing the skin to lose its self-defense ability, deteriorating the barrier function.

With the improvement of science and technology and the improvement of living standard of people, the requirement on an efficacy type skin care product is higher and higher, wherein the anti-aging skin care product is endlessly developed, but a plurality of eye cream products aiming at the fine lines of eye skin are not enough, and the efficacy of most of the eye cream products is not obvious enough.

Disclosure of Invention

In order to solve the problems, the invention aims to provide an eye cream which can smooth skin, smooth fine lines and tighten skin.

The specific technical scheme of the invention is as follows:

an eye cream for smoothing fine wrinkles and tightening skin mainly comprises the following components in percentage by weight: 1-5% of an extract of spilanthol camomile (Acmelaoleracea), 0.5-5% of an extract of Gigartina astera (GIGARTINA STELLATA), and 0.1-0.5% of a 1 ‰ aqueous solution of palmitoyl tripeptide-1.

In some embodiments, the eye cream for smoothing fine lines and tightening skin mainly comprises the following components in percentage by weight: 3 percent of an extract of spilanthol indicum (ACMELLA OLEACEA), 1 percent of an extract of Gigartina astera (GIGARTINA STELLATA) and 0.25 percent of a 1-thousandth aqueous solution of palmitoyl tripeptide-1.

In some embodiments, the eye cream for smoothing fine wrinkles and tightening skin further comprises the following components in percentage by weight: 1-5% of hydrolyzed elastin.

The embodiment of the invention also provides a wrinkle-smoothing eye cream which comprises the following components in percentage by mass:

。

the technical scheme provided by the embodiment of the invention has the following beneficial effects: the invention selects the extracts of the spilanthes camomillae (ACMELLALERACEA), the extracts of the taxus asterias (GIGARTINA STELLATA) and the palmitoyl tripeptide-1, can promote the differentiation, keratinization and exfoliation of the skin cuticle, improve the skin hydration degree, increase the content of skin collagen and elastin, obviously improve the internal tension and elasticity of the skin, strengthen the activity of the skin collagen, improve and reduce fine wrinkles from inside to outside and improve the sense of tightness. The embodiment of the invention proves that the wrinkle-removing cream has good wrinkle-removing effect through efficacy evaluation of volunteers.

Detailed Description

In order to make the objects, technical solutions and advantages of the present invention more apparent, embodiments of the present invention will be described in further detail below, but the embodiments of the present invention are not limited thereto, and process parameters or conditions not particularly noted may be performed with reference to conventional techniques.

The spilanthol camomile (ACMELLA OLEACEA) extract of the present invention is enriched in spilanthol and has a muscle-relaxing effect similar to botulinum toxin, and suitable spilanthol camomile extracts may include: gatuline Expression AF (from GATTE FOSSE Jia Fa lion, France).

The taxus asterias (GIGARTINA STELLATA) extract is an extract rich in carrageenan oligosaccharides obtained by an enzymatic hydrolysis method, has the effects of enhancing skin hydration, improving skin epidermis renewal and strengthening skin barrier, and suitable taxus asterias (GIGARTINA STELLATA) extracts can comprise: healthyskin skin care (from Lessonia, France).

The palmitoyl tripeptide-1 is a fatty acid modified polypeptide, can perform feedback regulation and control on the processes of connective tissue reconstruction and cell proliferation, and can promote the generation of skin repair protein in the process of skin repair. Suitable palmitoyl tripeptide-1 may include: collagen peptide^TM(from Shenzhen Weiqi Biotech Co., Ltd.)

The hydrolyzed elastin of the invention has small molecular weight, is easy to be absorbed by skin, directly promotes and participates in the synthesis of the skin elastin, achieves the effect of enhancing the skin elasticity (plump), and suitable hydrolyzed elastin can comprise: marine elastin (from i.r.a.istituto.ricerche applications srl, italy).

Example 1

The wrinkle-smoothing eye cream comprises the following components in percentage by mass:

。

the preparation method of the wrinkle-smoothing eye cream comprises the following steps: putting the phase A into a main pot, stirring and heating to 90 ℃, and homogenizing for 10 minutes; putting the phase B into an oil pan, heating to 75 ℃ for dissolving, pumping into a main pan, homogenizing at high speed for 15 minutes, preserving heat for 20 minutes, and cooling to 60 ℃; adding phase C into main pot, stirring, cooling to 45 deg.C, adding phase D into main pot, and stirring.

Comparative example 1

。

Test 1 human efficacy test

The wrinkle-soothing eye creams prepared in example 1 and comparative example 1 of the present invention were subjected to a human efficacy test, and a commercially available eye cream of a brand declared to have a wrinkle-removing effect was used as a comparative group 5. The specific test method is as follows:

(1) selecting 30 subjects of 30-45 years to take test;

(2) at the first visit (initial value), before the test, the subjects cleaned their face with a mild facial cleanser uniformly, wiped dry with a paper towel, at test ambient temperature: 20 ℃ to 22 ℃, humidity: sitting still for 30min in 40-60% environment, and collecting wrinkle data with VISIA skin detector;

(3) and (3) repeating the step (2) to collect wrinkle data by using a VISIA skin detector for the next visit, wherein the test time is 8 weeks. Data were collected once at week 4, week 6, and week 8, respectively (error of 1 day before and after acceptance)

(4) All other eye products were banned throughout the study, and changes to conventional skin care products, facial cleanser were not permitted one week prior to the study start and during the study.

[ parameter interpretation ]

(1) And (3) wrinkle feature counting: the higher the number of wrinkles reflecting the eyes, the higher the number of wrinkles indicating the number of wrinkles in the eyes.

(2) Wrinkle score: the higher the value of the number of the eye wrinkles, the larger the size, area and density of the eye wrinkles are reflected.

The specific test results are shown in table 1.1 ~ 1.2.2.

Table 1.1 test group efficacy evaluation record table

TABLE 1.2 comparative efficacy evaluation record sheet

The test results of the above table 1.1 ~ 1.2.2 show that the wrinkle feature count change rate of the test groups 1-3 is in the range of-10% ~ -15%, the wrinkle score change rate of the test groups 4-5 is in the range of-8% ~ -10%, the wrinkle feature count change rate of the test groups 4-5 is in the range of-17% ~ -20%, the wrinkle score change rate is in the range of-12% ~ -15%, the change rate of the wrinkle feature count change rate and the change rate of the wrinkle score of the blank comparison group 1 are both less than 1% and have small changes, the wrinkle feature count change rate of the comparison groups 2-4 is in the range of-4% ~ -5%, the wrinkle score change rate is in the range of-3% ~ -3.5%, and the wrinkle feature count change rate of the commercially available product comparison group 5 is-3.98%, and the wrinkle score change rate is-3.74%.

The above description is only a preferred embodiment of the present invention, and is not intended to limit the present invention in any way, so that any simple modification, equivalent change and modification made to the above embodiment according to the technical spirit of the present invention will still fall within the scope of the technical solution of the present invention without departing from the content of the technical solution of the present invention.

Claims

1. The eye cream for smoothing fine wrinkles and tightening skin is characterized by mainly comprising the following components in percentage by weight: 1-5% of an extract of spilanthol camomile (ACMELLA OLEERACEA), 0.5-5% of an extract of Gigartina astera (GIGARTINA STELLATA), and 0.1-0.5% of a 1 ‰ aqueous solution of palmitoyl tripeptide-1.

2. The eye cream for smoothing fine lines and firming skin according to claim 1, which is characterized by mainly comprising the following components in percentage by weight: 3 percent of an extract of spilanthol indicum (ACMELLA OLEACEA), 1 percent of an extract of Gigartina astera (GIGARTINASTELLATA) and 0.25 percent of a 1-thousandth aqueous solution of palmitoyl tripeptide-1.

3. The eye cream for smoothing fine lines and firming skin according to claim 1 or 2, which is characterized by further comprising the following components in percentage by weight: 1-5% of hydrolyzed elastin.

4. The wrinkle-smoothing eye cream is characterized by comprising the following components in percentage by mass:

。